Fibcare ® shows correlation with fibrinogen levels by the Clauss method during cardiopulmonary bypass

• Published in: Nagoya journal of medical science Vol. 85; no. 2; pp. 310 - 318
• Main Authors: Yamada, Akihiro, Tamura, Takahiro, Imaizumi, Takahiro, Kubo, Yoko, Nishiwaki, Kimitoshi
• Format: Journal Article
• Language: English
• Published: Japan Nagoya University 01.05.2023
• Subjects: Blood Coagulation Tests - methods; Cardiopulmonary Bypass; Fibrinogen - analysis; Humans; Hypothermia; Original Paper; Retrospective Studies; cardiopulmonary bypass; platelet mapping; Fibcare; fibrinogen; thromboelastography
• ISSN: 0027-7622; 2186-3326
• DOI: 10.18999/nagjms.85.2.310

Central laboratory measurements are time consuming, while rapid fibrinogen level measurements within the operating room improve transfusion strategies. We aimed to clarify the correlation between fibrinogen concentrations (measured using Fibcare and the Clauss fibrinogen assay in a central laboratory) during cardiovascular surgery with cardiopulmonary bypass. Data of patients whose Fibcare, traditional laboratory-based testing, and thromboelastographic results were measured using the same blood sample during cardiopulmonary bypass from February 2021 to January 2022 were retrospectively examined. We analyzed correlation in categories of body temperature during cardiopulmonary bypass: total cases, mild hypothermia (28-34°C), and moderate or severe hypothermia (<28°C). The Clauss fibrinogen assay was performed in 123 cases, Fibcare in 107, and thromboelastography in 91. For mild hypothermia, moderate or severe hypothermia, and overall, the root mean squared error and R-square in Fibcare were 16.1 and 0.86, 13.1 and 0.87, and 14.9 and 0.87, respectively, and for thromboelastography, they were 3.26 and 0.74, 2.70 and 0.79, and 3.08 and 0.75, respectively. A significant relationship was noted between Fibcare and Claus fibrinogen analysis regardless of body temperature during cardiopulmonary bypass. The measurement of fibrinogen levels using Fibcare allows for faster transfusion preparation than that of the traditional Clauss fibrinogen assay.